Japanese encephalitis virus (JEV) envelope (E) protein holds great promise for use in the development of a recombinant vaccine. Purified recombinant E (rE) protein may be useful for numerous clinical applications; however, there are limitations in using the Escherichia coli expression system for producing high-quality rE protein. Therefore, in this study, the yeast expression system was used to generate the rE protein. For protein production using the yeast system, the full-length JEV E gene was cloned into Pichia pastoris. SDS-PAGE and immunoblotting analysis demonstrated that the rE protein had a molecular mass of 58 kDa and was glycosylated. The predicted size of the mature unmodified E protein is 53 kDa, suggesting that post-translational modifications resulted in the higher molecular mass. The rE protein was purified to greater than 95% purity using combined ammonium sulfate precipitation and a SP-Sepharose Fast Flow column. This purified rE protein was evaluated for immunogenicity and protective efficacy in mice. The survival rates of mice immunized with the rE protein were significantly increased over that of Hyphantria cunea nuclear polyhedrosis virus E protein (HcE). Our results indicate that the rE protein expressed in the P. pastoris expression system holds great promise for use in the development of a subunit vaccine against JEV.
Japanese encephalitis virus (JEV), which is a member of the genus Flavivirus in the family Flaviviridae, is the leading cause of endemic and epidemic viral encephalitis in Asia [3] . JEV is a single-stranded, positive-sense linear RNA, belonging to the family Flaviviridae [10] . The genomic RNA of JEV is approximately 11 kb long and has been shown to display positive polarity [17] . The RNA genome of JEV is infectious, and can be translated into three structural and several nonstructural proteins [3] .
The E protein of this virus is 500 amino acids in length with a molecular mass of 53 kDa, and it contains a single potential carbohydrate attachment site at the Asn-X-Ser/ Thr sequence, which is approximately 50 amino acids from the N-terminus. The E protein has been detected in both glycosylated [12] and nonglycosylated forms [16, 18] and is organized into peplomeric "spikes." These spikes provide the virion with its characteristic morphology, and the E protein is believed to be important in the pathogenicity of several viruses, either by defining cellular tropisms [13] or by influencing viral penetration [12] . Therefore, the E protein constitutes a major immunogen in viral infection [12] , cell fusion, virus maturation, and induction of protective immunity [17] . Recently, JEV-specific monoclonal antibodies were shown to be capable of protecting mice against a lethal challenge of JEV [2] .
JEV infectivity is readily lost owing to exposure to heat, acid, lipid solvents, and detergents. Lipid solvents or ionic detergents deactivate both infectivity and hemagglutination (HA) activity. These determinants appear to be correlated with the important biological properties of HA and neutralization. In previous studies, the biological functions of the JEV structural proteins were assessed, and it was suggested that the envelope protein is related to HA and neutralizing activity [4, 14] .
Since JEV was identified as the etiological agent of acute encephalitis syndrome (AES), a great deal of interest has arisen in the use of JEV proteins for diagnostic tests, as well as in vaccine formulations. Proteins generated by recombinant DNA techniques constitute attractive alternatives to virion-derived materials, owing to their specificity and ease of handling. Several expression systems have been previously used to generate the E protein of JEV including Escherichia coli [8] , yeast [15] , insect cells [7, 9] , and mammalian cells [5] . Because of the high level of expression obtained using the baculovirus system, this virus system provides the opportunity to study the processing and biological properties of proteins of mammalian origin in insect cells.
Pichia pastoris is one of the most widely used systems for obtaining recombinant protein by heterologous expression. P. pastoris is a methylotrophic yeast genetically engineered to express proteins for research and development. This system uses strong promoters such as the alcohol oxidase (AOX1) promoter, which allows for the production of large amounts of the target protein with ease and low cost relative to other eukaryotic systems. Furthermore, yeast is suitable for large-scale production in fermenters where parameters such as pH, aeration, and carbon source feed rate can be controlled.
In this study, we examined the expression of the JEV E protein using the P. pastoris expression system. In addition, the secreted protein was immunologically characterized and compared with the E protein produced by the Hyphantria cunea nuclear polyhedrosis virus (HcNPV). Furthermore, the rE protein was shown to protect mice against a lethal JEV challenge. This is the first study on the purification of a highly active rE using the yeast P. pastoris expression system.
MATERIALS AND METHODS

Viruses, Cells, and Media
The JaGar-1 strain of JEV and the Black Goat Kidney (BGK) cell were used to propagate the virus. The virus was passaged three times in the brains of suckling mice. After an additional passage in suckling mice, BGK cells were infected and the infected cell culture medium was used as infectious inoculums for all experiments for which virus propagation was required. The BGK cells were regularly maintained in α-MEM supplemented with 5% fetal bovine serum (FBS) and penicillin/streptomycin (100 U/ml).
E. coli transformants were selected on Luria-Bertani agar plates containing 25 µg/ml zeocin. Pichia pastoris transformants were selected on YPDS plates (1% yeast extract, 2% peptone, 2% dextrose, 1 M sorbitol, 2% agar, and 100 µg/ml zeocin), and then an YPD plates (the same as YPDS except that sorbitol was omitted) containing 500 µg/ml zeocin for isolation of single colonies. The BMGY medium contained 1% yeast extract, 2% peptone, 100 µM potassium phosphate (pH 6.0), 1.34% yeast nitrogen broth, 0.4 µg/ml biotin, and 1% glycerol. The BMMY medium was the same as the BMGY medium except that glycerol was replaced by methanol. The YPG medium contained 1% yeast extract, 2% peptone, and 1% glycerol.
Bacterial Strains, Plasmid, and Other Reagents E. coli DH5α was purchased from Invitrogen. The pTZ18R and pSLl190 plasmids were used for DNA sequencing (Phamarcia). The pPICZα plasmid was used for expression in the yeast X-33 cells (Invitrogen). All primers were designed based on the genomic sequence of the JEV JaGar-1 strain (GenBank Accession No. AF069076). The primer was designated JEF (CGCTCGAGTTTAATTGTCTGG GAATGG), and the reverse primer was designated JER (CGC TCGAGTTAAGCATGCACATTGGTCGC). The 5' and 3' ends contained the XhoI site. All restriction endonucleases, T4 DNA ligase, and calf intestinal phosphatase (CIP) were purchased from New England Biolabs (MA, USA) and Boehringer Mannheim. [α - The zeocine-based Pichia pastori expression vector containing the E gene of JEV. The 1.5 kb fragment was cloned into the pPICZα vector, which was designated pPICZα-E. Lane 1, 1 kb DNA ladder; lane 2, pPICZα-E digested with XhoI. (C) Detection of the rE protein secreted from the supernatants. Eight yeast clones were randomly selected from a 500 µg/ml Zeocin YPD plate, seeded into 5 ml of BMGY medium, and incubated for 24 h at 28 o C. Cells were collected by centrifugation, resuspended in BMMY medium, and incubated for an additional 72 h at 28 o C. Methanol was added to a final concentration of 0.5% every 72 h to maintain induction of rE expression. The presence of rE in the culture media was detected by Western blotting using anti-His antibodies. SDS-PAGE separation and protein transferring to the nitrocellulose membrane. The data are representative of five independent experiments. Lane 1. Molecular marker, lanes 2~9; rE1-rE8 represent the rE-producing yeast clones.
using primers for the JEV JaGar-1 strain. The PCR product of the JEV E gene was digested using the XhoI enzyme, and the 1.5 kb fragment was inserted and cloned into the XhoHI site of the pPICZα vector (Fig. 1 ). This recombinant plasmid was designated pPICZα-E and contained a C-terminus peptide encoding six histidine residues for detection and purification. Fifteen µl of the expression vector was linearized by digestion with StuI and transformed into 100 µl of P. pastoris X-33 by electroporation. Transfections were performed in 4-mm-gap cuvettes using a BTX ECM 830 electroporator with a single pulse of 280 V and 12 ms [1] . P. pastoris transformants were inoculated on YPDS plates containing 100 µg/ml zeocin. Resulting colonies were transferred to YPD plates containing 500 µg/ml zeocin. After incubation at 30 o C for 72 h, large colonies were picked and confirmed by PCR.
Heterologous Expression
An YPD plate was streaked with the P. pastoris X-33 strain. The plate was then incubated at 30 o C for 24 h. A single colony was inoculated into 25 ml of BMGY in a 200 ml flask. The cells were grown at 30 o C in a shaking culture until the OD 600 reached 2~6. This 25 ml culture was then used to inoculate 1 liter of BMGY (500 ml each in two 2 liter flasks) and the cells were grown at 30 o C with shaking until the culture reached the log growth phase. The cells were harvested using sterile centrifuge bottles by centrifuging at 2,500 ×g for 5 min at room temperature. To induce expression, the supernatant was decanted and the cell pellet was resuspended to an OD 600 = 2.0 in BMMY without centrifugation. The culture was aliquoted into several 2 L flasks (600 ml in each flask). The flasks were then covered with cheesecloth or sterile gauze and returned to the incubator. The cells were allowed to continue to grow at 30 o C with shaking. Methanol 100% was added to the culture at a concentration of 0.5% (3 ml methanol in 600 ml culture) every 12 h until 72 h. The cells were harvested by centrifuging at 4,000 ×g for 10 min at room temperature. The supernatant was saved and filtered through 0.2 mM filter units. The supernant was stored at -80 o C until used.
Purification of the rE Protein
After 72 h of induction with methanol, the culture supernatant was collected following centrifugation at 12,000 ×g for 10 min. Then 200 ml of the culture supernatant was precipitated by adding 75% (w/v) ammonium sulfate, and then centrifuged at 15,000 ×g and 4 o C for 30 min to collect the precipitate. The precipitate was dissolved in 90 ml of 20 mM Tris-Cl buffer (pH 7.4) and dialyzed in a dialysis bag against 1 liter of dialysis buffer (20 mM Tris-Cl buffer, pH 7.4) overnight at 4 o C. The dialyzed sample was filtered through a 0.22 µm filter and loaded onto a Zn-Chelate Sepharose Fast Flow column that was equilibrated with 50 ml of 20 mM Tris-HCl (pH 7.4) using an HPLC assay and then eluted with imidazole at concentrations increasing from 0 to 50 mM. The pH was reduced to ~6 with acetic acid and the sample was digested for 90 min using Endo H (1,000 U/ml) at room temperature. The pH was then increased to ~7.5 with TrisHCl (pH 8.5). The SP-Sepharose Fast Flow column was washed with 0.1 M NaCl and eluted with 0.25 M NaCl. The eluted solution containing the rE protein was concentrated, washed with PBS, lyophilized, and stored at -20 o C.
Immunological Assay
For immunoblotting, cells were lysed in an ice-cold lysis buffer containing 1% Triton X-100 in 20 mM Tris-HCl, pH 8.3, 150 mM NaCl, protease inhibitors, and phosphatase inhibitors. Postnuclear lysates were incubated for 1 h with the indicated antibody. Protein A-Sepharose beads (30 µl; Amersham Pharmacia) were added and incubated for 1 h at 4 o C. The proteins were separated by 10% SDS-PAGE and transferred to a nitrocellulose membrane for immunoblotting. The membranes were blocked with 5% milk in TBS (10 mM TrisHCl, pH 7.6, 150 mM NaCl) and incubated with antibodies. The primary antibodies were visualized by enhanced chemiluminescence (ECL, Amersham) after the addition of a secondary antibody, which was provided by Amersham. The serum neutralization (SN) test was carried out using the 50% plaque reduction method. Antibody titer was calculated as the reciprocal of the highest serum dilution that resulted in 50% plaque reduction.
To identify antigen-specfic IgG subclass antibodies, 96-well plates were coated with 0.5 µg/ml of purified rE, deglycosylated E, and HcE proteins in carbonate buffer and incubated overnight at 4 o C. Following incubation with blocking buffer, 10-fold diluted immunized sera were added to the wells and incubated at room temperature for 2 h. After washing, alkaline phosphatase-conjugated goat anti-mouse IgG 1 and IgG 2a isotype-specific antibodies (SouthernBiotech, Birmingham, USA) were utilized as secondary antibodies. The wells were developed using p-nitrophenyl phosphate as a substrate, and then the absorbance was measured at 405 nm. The reciprocal of the highest dilution with an absorbance of at least twice that of normal serum was used as the ELISA end point.
Mice Protection Assay
Groups (n = 10) of 4-week-old mice were immunized intramuscularly with 10 mg of purified rE, deglycosylated E, or HcE protein. The purified rE, deglycosylated E, or HcE protein was administered with aluminum hydroxide-based adjuvant Alhydrogel (Superphos Biosector, Denmark). Booster doses were given subsequently 4 and 5 weeks later with the same immunogen and adjuvant. A control group of mice was immunized with the JE vaccine and boosted as described above. Mice were challenged 6 weeks post-immunization with a highly lethal dose (100LD 50 ) of live JEV, which was administered intracerebrally since adult mice are refractory to peripheral JEV infection.
Statistical Analysis
All data were analyzed using GraphPad Prism 5.0. P<0.05 was considered significantly different.
RESULTS
Plasmid Construction and Selection of P. pastoris Transformants The JEV E gene was amplied by RT-PCR and then cloned into the pPICZa vector, where it was under the control of the AOX1 promoter (Fig. 1A) . The cloned E gene was verified by digestion with the restriction enzyme XhoI and was found to contain a fragment that was approximately 1.5 kb (Fig. 1B, lane 2) . The pPICZa-E plasmid was transformed into P. pastoris and plated on YPDS medium containing 100 µg/ml of zeocin. Colonies grown on the YPDS-zeocin plate were replated on YPD plates containing 500 µg/ml of zeocin. Following 72 h of incubation at 30 o C, single colonies were selected and confirmed by PCR.
Expression of JEV rE Protein in P. pastoris X-33 cells
The resulting plasmid, pPICZα-E, was transformed into P. pastoris. Of the single colonies that grew on YPD containing 500 µg/ml of zeocin, eight clones were selected to test rE protein expression, and expression was analyzed by immunoblot (Fig. 1C) . All selected clones expressed the rE protein with a molecular mass of 58 kDa, which was slightly larger in yeast when compared with native rE expressed in HcNPV (53 kDa; data not shown). This result suggests that the protein expressed in yeast might be glycosylated. No protein from the untransformed P. pastoris X-33 reacted with the anti-JEV antibody (data not shown). As shown in Fig. 1C , the rE-5 clone produced the highest expression of rE and therefore was used for the subsequent time-course studies. To determine the optimal time for rE expression, the rE-5 clone was seeded in the culture medium and samples were collected at 24, 48, and 72 h. The level of rE protein expression increased over time and the strongest signal was observed at 72 h (data not shown). Therefore, an incubation of 72 h was determined to be optimal at pH 7.0.
The JEV E gene was expressed in P. pastoris X-33 cells. Coomassie Blue staining of the crude undiluted lysates, diluted lysates, and 25~75% ammonium sulfate precitated proteins after SDS-PAGE ( Fig. 2A, upper panel) revealed two major bands at 58 and 53 kDa, which were detected by immunoblot using an anti-His antibody ( Fig. 2A, lower  panel) . To examine whether the rE harvested from the yeast expression system was glycosylated, the purified rE from supernatant was treated with Endo H (Endo-β-Nacetylglucosaminidase H) to remove any N-linked glycosylations and subjected to SDS-PAGE and Western blotting analysis. As shown in Fig. 2B , the pretreated rE had the expected molecular mass of approximately 58 kDa, whereas the treated rE exhibited two distinct bands with one large band at 53 kDa (Fig. 2B) . The shift in the band position postEndo H treatment indicates that the rH was glycosylated in the P. pastoris expression system. The enzyme Endo H is a highly specific endoglycosidase that cleaves asparaginelinked mannose-rich oligosaccharides. As previously mentioned, the protein expressed in yeast was glycosylated by both O-or N-glycosidic linkages. Perhaps the emergence of the two bands was due to the ability of the Endo H to only remove the N-form of glycosylation from the rE protein. Overall, it is clear that the rE protein was secreted from the P. pastoris and was glycosylated post-translationally.
Purification of the JEV rE Protein
To determine the optimal conditions for scale-up protein production, the rE-5 clone was used and expression was induced for 72 h incubation in the presence of 1% methanol. The rE protein in the supernatant was purified by SPSepharose Fast Flow (Fig. 3A) . After 72 h of induction in the flask, the culture was centrifuged and 50 ml of the supernatant was precipitated using 75% saturated ammonium sulfate. Under these conditions, 19.4 mg of protein was present in the pellet (Fig. 3B, lane 1) . After dialysis, the solution containing the rE protein was subjected to Zn chelate Sepharose Fast Flow, and 17.8 mg of protein was acquired after elution (Fig. 3B, lane 5) . After Endo H digestion, 80.6% of the rE was recovered (Fig. 3B, lane 8) . The elution solution was concentrated and then further purified on SP Sepharose Fast Flow. A total of 15.6 mg of protein was collected after this step and the contaminating proteins of high molecular weight were eliminated. The rE recovery yield following SP Sepharose Fast Flow was about 49.1%. Overall, approximately 9.5 mg of pure rE protein was obtained from 50 ml of culture supernatant with a purity of up to 95%.
Immune Response of Mice Given rE Protein
To evaluate the immunogenicity of the recombinant proteins, groups of 10 mice were immunized with purified rE, deglycosylated E, HcE protein, or inactivated JEV vaccine emulsified with adjuvant. After the second booster dose, the mice were bled and the level of neutralizing antibodies was measured. A low level of neutralizing antibodies were observed in sera from the mice immunized with deglycosylated rE and HcE protein and inactivated JEV vaccine (Fig. 4) . Although the SN titers before the virulent virus challenge were low at 1:2 to 1:4 in the rE and deglycosylated E immunized mice, SN titers from all the immunization groups increased from 1:4 to 1:16 after the lethal JEV challenge. No detectable neutralizing antibody response was observed in the control group.
Protection of the Immunized Mice Against Lethal JEV
In order to investigate whether P. pastoris expressed recombinant E protein was immunologically functional, groups of mice were immunized with purified rE, deglycosylated E, HcE protein, or inactivated JEV vaccine. One week after the second immunizing boost, the mice were challenged with a virulent JEV strain (100LD 50 /0.5 ml). In these challenge studies, the survival rates of mice immunized with purified rE or deglycosylated E proteins were significantly increased over that of the control mice as shown in Fig. 5 . Over 90% of the mice that received the purified rE and deglycosylated E proteins survived after lethal challenge of JEV. In contrast, only 80% of the mice immunized with the HcE recombinant protein were protected. Mice immunized with the JEV vaccine were completely protected.
Immunoglobulin Subtypes Elicited by Immunization with the rE Protein
To evaluate whether the immunization of recombinant proteins may affect the isotype, IgG 1 and IgG 2a levels in the sera collected before and after the challenge of virus were measured. Following the second booster dose, the IgG 1 antibody levels were increased in the rE and deglycosylated E immunized groups (Table 1 ). The titers of IgG 1 antibodies were approximately two and three times higher than those of the IgG 2a antibody as compared with the control group. Mice immunized with the inactivated JEV vaccine induced relatively low titers of the IgG 2a antibody. However, the The data are representative of five independent experiments. Mice were immunized with rE, deglycosylated rE, HcE, or JE vaccine with aluminum hydroxide-based adjuvant Alhydrogel. Serum specimens collected one week after the second booster were assayed for SN titer. *P < 0.01 and **P < 0.05. The data are representative of five independent experiments. To evaluate whether the immunization of recombinant proteins may affect isotypes of immunoglobulins, the immunoglobulin subtypes of IgG 1 and IgG 2a were measured from sera collected. JEV-specific serum IgG subclasses were determined at 2 weeks after the third immunization (Before) and 2 weeks after the challenge (After), respectively.
IgG 2a antibody level increased significantly in most of the immunized groups 2 weeks after the challenge.
DISCUSSION
The E protein, a major structural protein of the Flavivirus virion, appears to play a dominant role in receptor binding, generation of neutralizing antibodies, and induction of protective immunity [7, 9] . A number of expression systems have been used for the production of JE viral recombinant proteins. Expression of the rE protein has been achieved in several hosts such as Escherichia coli [8, 13] , yeast [15] , insect cells [7, 9] , and mammalian cells [6] . Although JE viral proteins have been expressed successfully in E. coli, the proteins did not elicit neutralizing antibody and protective immunity [8] . This might be due to lack of properly folded and correctly assembled recombinant protein.
The baculovirusinsect cell expression system allows for high levels of expression of the recombinant proteins with proper folding and post-translational processing [5, 11] . However, this approach is expensive and produces low yields. In this study, P. pastoris yeast was successfully used as an expression system for generating immunologically functional rE protein and thus can be used as an alternative to prokaryotic expression systems. We demonstrate here that immunologically reactive rE was secreted from the P. pastoris yeast expression system. Furthermore, we developed a purification strategy and protocol to purify rE from the culture medium of P. pastoris yeast cells. SDS-PAGE and immunoblotting analysis of the culture medium using methanol-induced expression yeast clones demonstrated that the rE was secreted into the culture medium, had a molecular mass of 58 kDa, and was glycosylated. The predicted size of the mature unmodified E polypeptide was 53 kDa, which suggests that eukaryotic post-translational modifications increased the molecular weight of the protein. The recombinant protein was purified to greater than 95% purity using a combined ammonium sulfate precipitation with SP-Sepharose Fast Flow column.
In order to examine the immunogenicity of the recombinant proteins, mice were immunized with the expressed proteins. The rE protein was more immunogenic than the HcE protein in the SN test (Fig. 4) . Compared with the HcE, expressed proteins were equally antigenic, but elicited only low levels of serum neutralizing antibodies. Based on these results, although the JEV proteins expressed by the recombinant baculovirus produced weak immune responses, they induced sufficient priming activities for protection.
In the survival experiments, the JEV vaccine group was completely protected. The rE protein proved to be a better immunogen in protection against lethal JEV challenge than the HcE protein. The protection rate mediated by the rE protein was clearly superior to that of E protein expressed in E. coli [8] .
The IgG antibody isotype reflects the type of T-helper cell immune responses that are generated after immunization. IgG 2a isotype indicates Th1-cell activation, which is associated with the development of a cell-mediated immune response. The IgG 2a antibody was reported to be the major antibody subtype for neutralizing viruses, and our results showed that immunization with the E proteins induced a higher IgG 1 titer than IgG 2a titer, indicating this protein produced Th2-cell responses. In addition, the IgG 2a levels of the mice immunized with recombinant proteins were somewhat increased after challenge.
In summary, our results demonstrated that JEV recombinant proteins expressed in P. pastoris cells stimulated immune responses that were capable of mediating significant protection against JEV. The SN antibody titers were induced by purified rE and deglycosylated E. This should allow easier monitoring of expressed antigens during the complex purification process required for the development of vaccines. This result may also provide helpful information for the development of subunit vaccines against JEV.
